Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.

This New Jersey bill mandates that all health insurance plans and Medicaid programs cover medically necessary tests and FDA-approved treatments designed to slow the progression of Alzheimer's disease and related disorders. The law requires these benefits to be treated the same as coverage for other conditions, specifically exempting them from step therapy requirements that often delay access to medications. These provisions apply to hospital, medical, and health service corporation contracts, as well as individual and group health insurance policies issued or renewed in the state. The coverage must be determined by a physician and align with the official labeling approved by the U.S. Food and Drug Administration.